Apogee Therapeutics, Inc. Annual Operating Income (Loss) in USD from 2022 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Apogee Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2022 to 2023.
  • Apogee Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$58.7M, a 141% decline year-over-year.
  • Apogee Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$178M.
  • Apogee Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$93M, a 203% decline from 2022.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.